86 related articles for article (PubMed ID: 23806966)
1. Private sector medicine-increasing excellence and viable alternative to state sector.
Gabric N; Lazic R
Psychiatr Danub; 2013 Jun; 25 Suppl 1():41-4. PubMed ID: 23806966
[No Abstract] [Full Text] [Related]
2. The Whittemore Peterson Institute: building bridges through private and public sector collaboration.
Whittemore A
Mol Interv; 2010 Jun; 10(3):120-6. PubMed ID: 20539029
[No Abstract] [Full Text] [Related]
3. Global health. Public-private partnerships proliferate.
Cohen J
Science; 2006 Jan; 311(5758):167. PubMed ID: 16410497
[No Abstract] [Full Text] [Related]
4. Translational research in Berlin hits a roadblock.
Abbott A
Nature; 2009 Jan; 457(7228):362-3. PubMed ID: 19158751
[No Abstract] [Full Text] [Related]
5. Public health. Public-private partnerships and scientific imperialism.
Tucker TJ; Makgoba MW
Science; 2008 May; 320(5879):1016-7. PubMed ID: 18497279
[No Abstract] [Full Text] [Related]
6. Analysis of senior population visits to physical medicine in Croatia.
Muzić V; Radović E; Marinović M
Coll Antropol; 2011 Sep; 35 Suppl 2():227-30. PubMed ID: 22220441
[TBL] [Abstract][Full Text] [Related]
7. Cuba--innovation through synergy.
Thorsteinsdóttir H; Sáenz TW; Quach U; Daar AS; Singer PA
Nat Biotechnol; 2004 Dec; 22 Suppl():DC19-24. PubMed ID: 15583679
[No Abstract] [Full Text] [Related]
8. South Africa--blazing a trail for African biotechnology.
Motari M; Quach U; Thorsteinsdóttir H; Martin DK; Daar AS; Singer PA
Nat Biotechnol; 2004 Dec; 22 Suppl():DC37-41. PubMed ID: 15583683
[No Abstract] [Full Text] [Related]
9. Indian biotechnology--rapidly evolving and industry led.
Kumar NK; Quach U; Thorsteinsdóttir H; Somsekhar H; Daar AS; Singer PA
Nat Biotechnol; 2004 Dec; 22 Suppl():DC31-6. PubMed ID: 15583682
[No Abstract] [Full Text] [Related]
10. South Korean biotechnology--a rising industrial and scientific powerhouse.
Wong J; Quach U; Thorsteinsdóttir H; Singer PA; Daar AS
Nat Biotechnol; 2004 Dec; 22 Suppl():DC42-7. PubMed ID: 15583684
[No Abstract] [Full Text] [Related]
11. The emergence of Egyptian biotechnology from generics.
Abdelgafar B; Thorsteinsdóttir H; Quach U; Singer PA; Daar AS
Nat Biotechnol; 2004 Dec; 22 Suppl():DC25-30. PubMed ID: 15583680
[No Abstract] [Full Text] [Related]
12. Supplemental health insurance: did Croatia miss an opportunity?
Langenbrunner JC
Croat Med J; 2002 Aug; 43(4):403-7. PubMed ID: 12187517
[TBL] [Abstract][Full Text] [Related]
13. Public-private partnerships. Going into labour.
Lissauer R
Health Serv J; 2001 Jun; 111(5761):24-5. PubMed ID: 11458560
[TBL] [Abstract][Full Text] [Related]
14. Agricultural IP and the public sector.
Huete-Pérez JA
Science; 2003 Oct; 302(5646):781-3; author reply 781-3. PubMed ID: 14593149
[No Abstract] [Full Text] [Related]
15. [Fractures and frontiers].
Chabot JM
Rev Prat; 1999 Feb; 49(4):407-8. PubMed ID: 10319692
[No Abstract] [Full Text] [Related]
16. Pathways across the valley of death: novel intellectual property strategies for accelerated drug discovery.
Rai AK; Reichman JH; Uhlir PF; Crossman C
Yale J Health Policy Law Ethics; 2008; 8(1):1-36. PubMed ID: 18564492
[No Abstract] [Full Text] [Related]
17. Health care of female outpatients in south-central India: comparing public and private sector provision.
Bhatia J; Cleland J
Health Policy Plan; 2004 Nov; 19(6):402-9. PubMed ID: 15459165
[TBL] [Abstract][Full Text] [Related]
18. Does hospital ownership affect patient experience? An investigation into public-private sector differences in England.
Pérotin V; Zamora B; Reeves R; Bartlett W; Allen P
J Health Econ; 2013 May; 32(3):633-46. PubMed ID: 23579025
[TBL] [Abstract][Full Text] [Related]
19. Public sector seeks to bridge 'valley of death'.
Moran N
Nat Biotechnol; 2007 Mar; 25(3):266. PubMed ID: 17344867
[No Abstract] [Full Text] [Related]
20. Public-private partnerships for solid waste management services.
Massoud M; El-Fadel M
Environ Manage; 2002 Nov; 30(5):621-30. PubMed ID: 12375083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
